Treatment of HIV infection in the older patient

References

• Ship JA, Wolff A, Selik RM. Epidemiology of acquired immune deficiency syndrome in persons aged 50 years or older. J. Acquir Immune Defic. Syndr. 4(1), 84–88 (1991).
   PubMed Web of Science ®Google Scholar
• ••Excellent review on the epidemiology of HIV in older patients in the early 1990s.
   Google Scholar
• Centers for Disease Control and Prevention. HIV/AIDS Surveillance Supplemental Report. Centers for Disease Control and Prevention, GA, USA, 1–44 (2002).
   Google Scholar
• ••Excellent update on the epidemiology ofHIV in the USA.
   Google Scholar
• Centers for Disease Control and Prevention. AIDS among persons aged 50 years — USA, 1991–1996. Morb. Mortal. Wkly Rep. 47(2), 21–27 (1998).
   PubMedGoogle Scholar
• •Excellent review on the epidemiology of HIV in older patients in the USA.
   Google Scholar
• Skiest DJ, Rubinstien E, Carley N, Gioiella L, Lyons R. The importance of comorbidity in HIV-infected patients over 55: a retrospective case-control study. Am. J. Med. 101(6), 605–611 (1996).
   PubMedGoogle Scholar
• •One of the initial studies indicating worse clinical outcomes in older HIV patients compared with younger patients.
   Google Scholar
• Saah AJ, Hoover DR, He Y, Kingsley LA, Phair JP. Factors influencing survival after AIDS: report from the Multicenter AIDS Cohort Study (MACS). J. Acquir Immune Defic. Syndr 7(3), 287–295 (1994).
   PubMed Web of Science ®Google Scholar
• •One of the initial studies indicating worse clinical outcomes in older HIV patients compared with younger patients.
   Google Scholar
• Ferro S, Salit IE. HIV infection in patients over 55 years of age. J Acquir. Immune Defic. Syndr 5(4), 348–353 (1992).
   PubMed Web of Science ®Google Scholar
• Operskalski EA, Stram DO, Lee H, et al Human immunodeficiency virus Type 1 infection: relationship of risk group and age to rate of progression to AIDS. Transfusion Safety Study Group. J. Infect. Dis. 172(3), 648–655 (1995).
   PubMedGoogle Scholar
• Phillips AN, Lee CA, Elford J, et al More rapid progression to AIDS in older HIV-infected people: the role of CD4+ T-cell counts. J. Acquir Immune Defic. Syndr 4(10), 970–975 (1991).
   PubMed Web of Science ®Google Scholar
• Blaxhult A, Granath F, Lidman K, Giesecke J. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS 4(2), 125–129 (1990).
   PubMedGoogle Scholar
• Sutin DG, Rose DN, Mulvihill M, Taylor B. Survival of elderly patients with transfusion-related acquired immunodeficiency syndrome. J. Am. Geriatr. Soc. 41(3), 214–216 (1993).
   PubMedGoogle Scholar
• Rothenberg R, Woelfel M, Stoneburner R, Milberg J, Parker R, Truman B. Survival with the acquired immunodeficiency syndrome. Experience with 5833 cases in New York City. N Engl J Med 317(21), 1297–1302 (1987).
   PubMed Web of Science ®Google Scholar
• Gaeta TJ, LaPolla C, Melendez E. AIDS in the elderly: New York City vital statistics. J. Emerg. Med 14(1), 19–23 (1996).
   PubMedGoogle Scholar
• Gordon SM, Thompson S. The changing epidemiology of human immunodeficiency virus infection in older persons. J Am. Geriatr Soc. 43(1), 7–9 (1995).
   PubMedGoogle Scholar
• Lemp GF, Payne SF, Neal D, Temelso T, Rutherford GW. Survival trends for patients with AIDS. J. Am. Med Assoc. 263(3), 402–406 (1990).
   PubMed Web of Science ®Google Scholar
• Rosenberg PS, Goedert JJ, Biggar RJ. Effect of age at seroconversion on the natural AIDS incubation distribution. Multicenter hemophilia cohort study and the international registry of seroconverters. AIDS 8(6), 803–810 (1994).
   PubMedGoogle Scholar
• Stehr-Green JK, Holman RC, Mahoney MA. Survival analysis of hemophilia-associated AIDS cases in the US. Am. J. Public Health 79(7), 832–835 (1989).
   PubMedGoogle Scholar
• Balslev U, Monforte AD, Stergiou G, et al Influence of age on rates of new AIDS-defining diseases and survival in 6546 AIDS patients. Scand J. Infect. Dis. 29(4), 337–343 (1997).
   PubMed Web of Science ®Google Scholar
• The Data collection on adverse events of Anti-HIV Drugs (DAD) study group. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med 349(21), 1993-2003 (2003).
   Google Scholar
• ••Excellent study evaluating the impact ofhighly active antiretroviral therapy on cardiovascular disease in HIV patients.
   Google Scholar
• Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidemia, and diabetes mellitus: a cohort study. Lancet 353(9170), 2093–2099 (1999).
   PubMed Web of Science ®Google Scholar
• Vittecoq D, Escaut L, Monsuez JJ. Vascular complications associated with use of HIV protease inhibitors. Lancet 351(9120), 1959 (1998).
   Google Scholar
• Moore RD, Keruly JC, Lucas GM. Increasing incidence of cardiovascular disease in HIV-infected persons in care. 10th Confirence on Retroviruses and Opportunistic Infections. Boston, MA, USA, 10–14 February 2003 (Abstract).
   Google Scholar
• Keitz SA, Bastian LA, Bennett CL, Oddone EZ, DeHovitz JA, Weinstein RA. AIDS-related Pneumocystis carinii pneumonia in older patients. J Gen. Intern. Med 11(10), 591–596 (1996).
   Google Scholar
• El Sadr W Gettler J. Unrecognized human immunodeficiency virus infection in the elderly. Arch. Intern. Med 155(2), 184–186 (1995).
   PubMedGoogle Scholar
• Stall R, Catania J. AIDS risk behaviors among late middle-aged and elderly Americans. The national AIDS behavioral surveys. Arch. Intern. Med 154(1), 57–63 (1994).
   PubMed Web of Science ®Google Scholar
• Homer RD, Bennett CL, Rodriguez D, et al Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia. Am. J. Respir. Crit. Care Med. 152(5), 1435 (1995).
   Google Scholar
• Butt AA, Dascomb KK, DeSalvo KB, Bazzano L, Kissinger PJ, Szerlip HM. Human immunodeficiency virus infection in elderly patients. S. Med J 94(4), 397–400 (2001).
   PubMedGoogle Scholar
• Abel T, Werner M. HIV risk behaviour of older persons. Eur J Public Health 13(4), 350–352 (2003).
   PubMedGoogle Scholar
• Mack KA, Ory MG. AIDS and older americans at the end of the twentieth century. J. Acquir. Immune Defic. Syndr. 33\(Suppl. 2) S68—S75 (2003).
   Google Scholar
• Chaisson RE, Keruly JC, Moore RD. Race, sex, drug use, and progression of human immunodeficiency virus disease. N Engl J. Med. 333(12), 751–756 (1995).
   PubMed Web of Science ®Google Scholar
• Betz M, Gebo KA, Barber E, et al Patterns of diagnoses in hospital admissions in a multi-state cohort of HIV-positive adults in 2001. Proc. Infect. Dis. Soc. Am. Boston, MA, USA, 30 September-3 October 2004.
   Google Scholar
• Gebo KA, Fleishman JA, Moore RD. Recent trends in HIV-related hospitalizations by selected diagnoses: a 12-state study. 10th Conference on Retroviruses and Opportunistic Infections. Boston, MA, USA, 10–14 February 2003 (Abstract).
   Google Scholar
• Reiter GS. Comprehensive clinical care: managing HIV as a chronic illness. AIDS Clin. Care 12(2), 13–19 (2000).
   PubMedGoogle Scholar
• Bastian L, Bennett CL, Adams J, Waskin H, Divine G, Edlin BR. Differences between men and women with HIV-related Pneumocystis carinii pneumonia: experience from 3070 cases in New York City in 1987. J. Acquir. Immune Defic. Syndr. 6(6), 617–623 (1993).
   Google Scholar
• Sorkin JD, Bolton PA, Greenblatt J, Sithisarankul P, Vlahov D, Graham NM. Age, gender, and other predictors of the wasting syndrome among HIV-1-infected injecting drug users. Epidemiology 6(2), 172–177 (1995).
   PubMedGoogle Scholar
• Perez JL, Moore RD. Greater effect of highly active antiretroviral therapy on survival in people agedyears comparedwith younger people in an urban observational cohort. Clin. Infect. Dis. 36(2), 212–218 (2003).
   PubMed Web of Science ®Google Scholar
• Douek DC, McFarland RD, Keiser PH, et al. Changes in thymic function with age and during the treatment of HIV infection. Nature 396(6712), 690–695 (1998).
   PubMed Web of Science ®Google Scholar
• Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Ann. Rev. Immunol 18 529–560 (2000).
   PubMed Web of Science ®Google Scholar
• Viard JP, Mocroft A, Chiesi A, et al. Influence of age on CD4 cell recovery in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy: evidence from the EuroSIDA study. J. Infect. Dis. 183(8), 1290–1294 (2001).
   PubMed Web of Science ®Google Scholar
• Operskalski EA, Mosley JW, Busch MP, Stram DO. Influences of age, viral load, and CD4+ count on the rate of progression of HIV-1 infection to AIDS. Transfusion Safety Study Group. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol 15(3), 243–244 (1997).
   Google Scholar
• Manfredi R, Chiodo F. A case-control study of virological and immunological effects of highly active antiretroviral therapy in HIV-infected patients with advanced age. AIDS 14(10), 1475–1477 (2000).
   PubMed Web of Science ®Google Scholar
• Manfredi R, Calza L, Cocchi D, Chiodo F. Antiretroviral treatment and advanced age: epidemiologic, laboratory, and clinical features in the elderly. J. Acquir. Immune Defic. Syndr. 33(1), 112–114 (2003).
   PubMed Web of Science ®Google Scholar
• Knobel H, Guelar A, Valldecillo G, et al. Response to highly active antiretroviral therapy in HIV-infected patients aged 60 years or older after 24 months follow-up. AIDS 15(12), 1591–1593 (2001).
   PubMedGoogle Scholar
• Goodkin K, Shapshak P, Asthana D, et al. Older age and plasma viral load in HIV-1 infection. AIDS 18\(Suppl. 1), S87—S98 (2004).
   PubMedGoogle Scholar
• •Most recent data on immune response and age.
   Google Scholar
• Maggiolo F, Ripamonti D, Arici C, et al. Simpler regimens may enhance adherence to antiretrovirals in HIV-infected patients. HIV Clin. Trials 3(5), 371–378 (2002).
   PubMedGoogle Scholar
• Hinkin CH, Castellon SA, Durvasula RS, et al. Medication adherence among HIV-positive adults: effects of cognitive dysfunction and regimen complexity. Neurology 59(12), 1944–1950 (2002).
   PubMed Web of Science ®Google Scholar
• Boufassa F, Dulioust A, Lascaux AS, et al. Lipodystrophy in 685 HIV-1-treated patients: influence of antiretroviral treatment and immunovirological response. HIV Clin. Trials 2(4), 339–345 (2001).
   PubMedGoogle Scholar
• Shah SS, McGowan JP, Smith C, Blum S, Klein RS. Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin. Infect. Dis. 35(10), 1238–1243 (2002).
   PubMed Web of Science ®Google Scholar
• Nokes K, Holzemer W, Corless I, Bakken S, Brown MA. Health-related quality of life in persons younger and older than 50 who are living with HIV/AIDS. Res. Aging 22(3), 290–310 (2000).
   Web of Science ®Google Scholar
• Gebo KA, Diener-West M, Moore RD. Hospitalization rates differ by hepatitis C status in an urban HIV cohort. J. Acquir. Immune Defic. Syndr. 34(2), 165–173 (2003).
   PubMed Web of Science ®Google Scholar
• Soriano V, Garcia-Samaniego J, Valencia E, Rodriguez-Rosado R, Munoz F, Gonzalez-Lahoz J. Impact of chronic liver disease due to hepatitis viruses as cause of hospital admission and death in HIV-infected drug users. Eur Epidemiol 15(1), 1–4 (1999).
   PubMed Web of Science ®Google Scholar
• Sulkowski MS. Drug-induced liver injury associated with antiretroviral therapy that includes HIV-1 protease inhibitors. Clin. Infect. Dis. 38\(Suppl. 2), S90—S97 (2004).
   PubMedGoogle Scholar
• NIH Consensus Statement on Management of Hepatitis C: 2002. NIH Consens. State Sci. Statements 19(3), 1–46 (2002).
   Google Scholar
• •Consensus statement from the National Institutes of Health on treatment recommendations for hepatitis C virus.
   Google Scholar
• de Torres M, Poynard T Risk factors for liver fibrosis progression in patients with chronic hepatitis C. Ann. Hepatol 2(1), 5-11(2003).
   PubMedGoogle Scholar
• Backus L, Phillips B, Boothroyd D, Burgess J, Rigsby M, Chang S. Center for Quality Management in Public Health, Veterans Health Administration and National HIV and Hepatitis C Program Office, Veterans Health. Administration. Hepatitis C coinfection increases mortality in HIV-infected US veterans treated with highly active antiretroviral therapy. 11th Conference on Retroviruses and Opportunistic Infictions. San Francisco, CA, USA, 8–11 February 2004 (Abstract 800).
   Google Scholar
• Rimland D, Guest J. Mortality in the HIV Atlanta VA cohort study: a 22-year analysis. 11th Confirmice on Retroviruses and Opportunistic Infections. San Francisco, CA, USA, 8–11 February 2004 (Abstract 873).
   Google Scholar
• Hinkin CH, Castellon SA, Atkinson JH, Goodkin K Neuropsychiatric aspects of HIV infection among older adults. J. Clin. Epidemiol 54\(Suppl. 1), S44—S52 (2001).
   Google Scholar
• Goodkin K, Wilkie FL, Concha M, et al Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. J Clin. Epidemid 54\(Suppl. 1), S35—S43 (2001).
   Google Scholar
• Rabkin JG, McElhiney MC, Ferrando SJ. Mood and substance use disorders in older adults with HIV/AIDS: methodological issues and preliminary evidence. AIDS 18\(Suppl. 1), S43—S48 (2004).
   PubMedGoogle Scholar
• Frisch M, Biggar RJ, Engels EA, Goedert JJ, for the AIDS—Cancer Match Registry Study Group. Association of cancer with AIDS-related immunosuppression in adults. J. Am. Med Assoc. 285(13), 1736–1745 (2001).
   PubMed Web of Science ®Google Scholar
• Engels EA. Human immunodeficiency virus infection, aging, and cancer. J. Clin. Epidemiol 54(12, Suppl. 1), S29—S34 (2001).
   PubMedGoogle Scholar
• ••Excellent review of cancer in olderHIV patients.
   Google Scholar
• The WIHS Collaborative Study Group. Cancer risk among participants in the women's interagency HIV study. J. Acquir. Immune Defic. Syndr. 36(4), 978–985 (2004).
   PubMedGoogle Scholar
• •New data on risk of cancer in HIV-positive women.
   Google Scholar
• Biggar RJ, Kirby KA, Atkinson JH, McNeel TS, Engels E, for the AIDS—Cancer Match Registry Study Group. Cancer risk in elderly persons with HIV/AIDS. J. Acquir. Immune Defic. Syndr (36), 861–868 (2004).
   PubMedGoogle Scholar
• •New data on the risk of cancer in older HIV patients.
   Google Scholar
• Hadigan C, Meigs JB, Corcoran C, et al Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy. Clin. Infict. Dis. 32(1), 130–139 (2001).
   PubMed Web of Science ®Google Scholar
• Saint-Marc T, Partisani M, Poizot-Martin I, et al. Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study. AIDS 14(1), 37–49 (2000).
   PubMedGoogle Scholar
• Periard D, Telenti A, Sudre P, et al. Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. Circulation 100(7), 700–705 (1999).
   PubMed Web of Science ®Google Scholar
• Mauss S. HIV-associated lipodystrophy syndrome. AIDS 14\(Suppl. 3), S197—S207 (2000).
   PubMedGoogle Scholar
• Manfredi R, Calza L, Chiodo E Gynecomastia associated with highly active antiretroviral therapy. Ann. Pharmacother. 35(4), 438–439 (2001).
   PubMedGoogle Scholar
• Brinkman K, Smeitink JA, Romijn JA, Reiss Mitochondrial toxicity induced by nucleoside-analog reverse-transcriptase inhibitors is a key factor in the pathogenesis of antiretroviral-therapy-related lipodystrophy. Lancet 354(9184), 1112–1115 (1999).
   PubMed Web of Science ®Google Scholar
• Carr A, Samaras K, Burton S, et al A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 12(7), F51—F58 (1998).
   Google Scholar
• Christeff N, Melchior JC, de Truchis P, Perronne C, Nunez EA, Gougeon ML. Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidemia and steroid hormone alterations. AIDS 13(16), 2251–2260 (1999).
   PubMed Web of Science ®Google Scholar
• Graham NM. Metabolic disorders among HIV-infected patients treated with protease inhibitors: a review. J. Acquir. Immune Defic. Syndr. 25\(Suppl. 1), S4—S11 (2000).
   PubMedGoogle Scholar
• Grunfeld C, Pang M, Doerrler W, Shigenaga JK, Jensen P, Feingold KR. Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. J. Clin. Endocrinol. 74(5), 1045–1052 (1992).
   PubMed Web of Science ®Google Scholar
• Riddler SA, Smit E, Cole SR, et al. Impact of HIV infection and HAART on serum lipids in men. J. Am. Med. Assoc. 289(22), 2978–2982 (2003).
   PubMed Web of Science ®Google Scholar
• Carr A, Cooper DA. Adverse effects of antiretroviral therapy. Lancet 356(9239), 1423–1430 (2000).
   PubMed Web of Science ®Google Scholar
• Jain RG, Furfine ES, Pedneault L, White AJ, Lenhard JM. Metabolic complications associated with antiretroviral therapy. Antivir. Res. 51(3), 151–177 (2001).
   PubMed Web of Science ®Google Scholar
• Galli M, Ridolfo AL, Gervasoni C. Cardiovascular disease risk factors in HIV-infected patients in the HAART era. Ann. 1VY Acad Sci. 946(1), 200–213 (2001).
   Google Scholar
• Fontas E, van Leth F, Sabin CA, et al Lipid profiles in HIV-infected patients receiving combination antiretroviral therapy: are different antiretroviral drugs associated with different lipid profiles? J. Infect. Dis. 189(6), 1056–1074 (2004).
   Google Scholar
• Van der Valk M, Kastelein JJ, Murphy RL, et al. Nevirapine-containing antiretroviral therapy in HIV-1 infected patients results in an anti-atherogenic lipid profile. AIDS 15(18), 2407–2414 (2001).
   PubMed Web of Science ®Google Scholar
• Dube MP, Stein JH, Aberg JA, et al. Guidelines for the evaluation and management of dyslipidemia in human immunodeficiency virus (HIV)-infected adults receiving antiretroviral therapy: recommendations of the HIV Medical Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group. Clin. Infect. Dis. 37(5), 613–627 (2003). New treatment guidelines for dyslipidemia in HIV patients.
   PubMed Web of Science ®Google Scholar
• Dube MP, Sprecher D, Henry WK, et al. Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Clin. Infect. Dis. 31(5), 1216–1224 (2000).
   PubMed Web of Science ®Google Scholar
• Henry K, Melroe H, Huebesch J, Hermundson J, Simpson J. Atorvastatin and gemfibrozil for protease-inhibitor-related lipid abnormalities. Lancet 352(9133), 1031–1032 (1998).
   PubMed Web of Science ®Google Scholar
• Mary-Krause M, Cotte L, Simon A, Partisani M, Costagliola D. Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected men. AIDS 17(17), 2479–2486 (2003).
   PubMed Web of Science ®Google Scholar
• Jutte A, Schwenk A, Franzen C, et al. Increasing morbidity from myocardial infarction during HIV protease inhibitor treatment? AIDS 13(13), 1796–1797 (1999).
   PubMedGoogle Scholar
• Tickerts V, Brodt H, Staszewski S, Stille W Incidence of myocardial infarctions in HIV-infected patients between 1983 and 1998: the Frankfurt HIV-cohort study. Eur. J. Med. Res. 5(8), 329–333 (2000).
   Google Scholar
• Holmberg SD, Moorman AC, Williamson JM, et al Protease inhibitors and cardiovascular outcomes in patients with HIV-1. Lancet 360(9347), 1747–1748 (2002).
   PubMed Web of Science ®Google Scholar
• De Gaetano Donati K, Rabagliati R, Iacoviello L, Cauda R. HIV infection, HAART, and endothelial adhesion molecules: current perspectives. Lancet Infect. Dis. 4(4), 213–222 (2004).
   PubMedGoogle Scholar
• Bowman L, Carlstedt BC, Hancock EF, Black CD. Adverse drug reaction (ADR) occurrence and evaluation in elderly in-patients. Pharmacoepidemiol. Drug Saf 5(1), 9–18 (1996).
   PubMedGoogle Scholar
• Egger T, Dormann H, Ahne G, et al Identification of adverse drug reactions in geriatric in-patients using a computerized drug database. Drugs Aging 20(10), 769–776 (2003).
   PubMed Web of Science ®Google Scholar